Merck Files Second Suit Against Teva Over Singulair

Law360, New York (May 16, 2007, 12:00 AM EDT) -- Not content to bring just one suit against Teva Pharmaceuticals USA over a generic version of asthma and allergy medication Singulair, Merck & Co. Inc. let a Barbados-based subsidiary file a second patent suit against the Israeli generics maker on Monday.

The second lawsuit, also in the U.S. District Court for the District of New Jersey, comes just over a month after Merck filed the first one. It charges Teva with the same claim of violating the Singulair patent by filing an Abbreviated New Drug Application...
To view the full article, register now.